<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05046418</url>
  </required_header>
  <id_info>
    <org_study_id>HAFSYN21</org_study_id>
    <nct_id>NCT05046418</nct_id>
  </id_info>
  <brief_title>Synbiotics Cohort Study</brief_title>
  <official_title>A Prospective, Observational, Cohort Study Investigating the Clinical Impact of Hypoallergenic Formulae With Synbiotics in Infants With Cow's Milk Allergy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nutricia UK Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nutricia UK Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study exploring the clinical outcomes of infants with cow's milk allergy who&#xD;
      are prescribed a hypoallergenic formula containing synbiotics.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A range of clinical outcomes will be collected from the medical records and in-person&#xD;
      assessment of 60 fully or partially formula fed infants (aged &lt;13 months) who are prescribed&#xD;
      a hypoallergenic formula containing synbiotics as part of usual clinical practice for the&#xD;
      dietary management of cow's milk allergy&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Healthcare use</measure>
    <time_frame>6 months</time_frame>
    <description>Data on the changes in healthcare use will be collected from medical records</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical impact and acceptability</measure>
    <time_frame>12 months post initiation of hypoallergenic formula containing synbiotics</time_frame>
    <description>Clinical outcomes related to CMA and parent/carer and infant acceptability will be assessed</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cows Milk Allergy</condition>
  <arm_group>
    <arm_group_label>Hypoallergenic formula containing synbiotics</arm_group_label>
    <description>Infants (aged &lt;13 months) with cow's milk allergy (CMA) who are prescribed a hypoallergenic formula containing synbiotics as part of usual clinical practice for the dietary management of CMA.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypoallergenic formula containing synbiotics</intervention_name>
    <description>An extensively hydrolysed formula containing synbiotics or an amino acid formula containing synbiotics.</description>
    <arm_group_label>Hypoallergenic formula containing synbiotics</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Exclusively or partially formula fed infants with confirmed or suspected CMA who have been&#xD;
        prescribed hypoallergenic formula containing synbiotics for the management of CMA as part&#xD;
        of clinical care.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged &lt;13 months&#xD;
&#xD;
          -  Confirmed or suspected CMA- based on healthcare professional (HCP) judgement&#xD;
&#xD;
          -  At baseline, parent(s) must already be exclusively or partially formula feeding their&#xD;
             child (with a hypoallergenic or non-hypoallergenic formula) or have already made the&#xD;
             decision to start exclusively or partially formula feeding&#xD;
&#xD;
          -  Recently prescribed a hypoallergenic formula containing synbiotics&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusively breastfed infants&#xD;
&#xD;
          -  Primary lactose intolerance&#xD;
&#xD;
          -  Enterally fed infants&#xD;
&#xD;
          -  Premature infants (born &lt;37 weeks) with a corrected age of less than 1 month&#xD;
&#xD;
          -  Infants with contraindications to the use of hyopallergenic formula containing&#xD;
             synbiotics&#xD;
&#xD;
          -  Major hepatic or renal dysfunction&#xD;
&#xD;
          -  Investigator concern around the ability of family to comply with protocol and&#xD;
             requirements of study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>13 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Nutricia UK</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Scientific Affairs Manager</last_name>
    <phone>07827085086</phone>
    <email>fiona.kinnear@nutricia.com</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 6, 2021</study_first_submitted>
  <study_first_submitted_qc>September 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>synbiotics</keyword>
  <keyword>paediatrics</keyword>
  <keyword>gut microbiome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Milk Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

